-
MedTech Company BioSig Technologies Deploys Disruptive Technology To Improve Arrhythmia Care
This article was previously published to Benzinga. Arrhythmia is a heart condition that causes it to beat either too fast, or irregularly. It’s triggered by abnormal electrical activity and affects the heart’s rhythm, leading it to beat out of sync with the rest of the body. Not every patient experiences arrhythmia in the same way, so it’s sometimes necessary for doctors to provide each patient with a personalized approach to treatment and recovery. Lifestyle choices and comorbidities, medication, stress and environmental factors can cause the heart to beat out of sync. The world is experiencing an uptick in arrhythmia cases linked to the after effects of COVID-19. Atrial fibrillation (AFib) is the…
-
Healthy Hearts and Healthy Wallets: Why one HealthTech Startup is a Must-Invest
Previously published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Last month, we saw a lot of great startups at the Benzinga Global Small Cap Conference. Many of them screamed, “This is an innovation tech stock you need to buy now!” But given the state of our world at this moment, one startup really stood out. Its key product is the Bioflux and it’s considered the “smallest, most accurate device on the market.” Our Current Problem Heart disease is the leading cause of death in men and women every year in the United States.…
You May Also Like
6 Companies That Could Fix Domestic Battery Supply Problem Using Little To No Emissions In The Mining of Essential Minerals
Happy Birthday, Shorty Produkshins!: Orlando Internet Marketing Company now 10!
LG and Google Partner, Bringing Stadia Gaming to OLED | Could outperform Xbox, PS5 in Global Gaming Markets
